Nepali Government has received approval for a loan of USD 165 million from the Asian Development Bank (ADB) to procure COVID-19 vaccines.
The fund will support Nepal’s National Deployment and Vaccination Plan and help procure around 15.9 million doses of COVID-19 vaccines, sufficient enough to inoculate about 6.8 million Nepalis.
“ADB’s support will help the Nepali Government procure much-needed COVID-19 vaccines to protect its citizens from the further spread of this disease,” mentioned ADB President Masatsugu Asakawa.
“It is essential that COVID-19 vaccines are quickly purchased and administered to help get the economy back on track by enabling the restoration of livelihoods and economic activities, as well as the resumption of educational and human development pursuits,” he added.
The ADB has offered support to Nepal through its USD 9 billion Asia Pacific Vaccine Access Facility launched in December 2020. The Facility aims at providing prompt and equitable vaccine-related support to ADB developing member countries.
However, the ADB’s fund must be used for vaccines that meet at least one of the APVAX eligibility criteria:
Stay Tuned to NepaliSansar for Latest Nepal COVID-19 Updates!